Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatments for Alpha-1 Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Augmentation Therapy
1.2.3 Cystic Fibrosis(CF)
1.2.4 Non-CF Bronchiectasis(NCFB)
1.2.5 Diabetes
1.2.6 Other
1.3 Market by Application
1.3.1 Global Treatments for Alpha-1 Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Treatments for Alpha-1 Market Perspective (2024-2034)
2.2 Treatments for Alpha-1 Growth Trends by Region
2.2.1 Global Treatments for Alpha-1 Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Treatments for Alpha-1 Historic Market Size by Region (2024-2024)
2.2.3 Treatments for Alpha-1 Forecasted Market Size by Region (2024-2034)
2.3 Treatments for Alpha-1 Market Dynamics
2.3.1 Treatments for Alpha-1 Industry Trends
2.3.2 Treatments for Alpha-1 Market Drivers
2.3.3 Treatments for Alpha-1 Market Challenges
2.3.4 Treatments for Alpha-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatments for Alpha-1 Players by Revenue
3.1.1 Global Top Treatments for Alpha-1 Players by Revenue (2024-2024)
3.1.2 Global Treatments for Alpha-1 Revenue Market Share by Players (2024-2024)
3.2 Global Treatments for Alpha-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Treatments for Alpha-1 Revenue
3.4 Global Treatments for Alpha-1 Market Concentration Ratio
3.4.1 Global Treatments for Alpha-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatments for Alpha-1 Revenue in 2022
3.5 Treatments for Alpha-1 Key Players Head office and Area Served
3.6 Key Players Treatments for Alpha-1 Product Solution and Service
3.7 Date of Enter into Treatments for Alpha-1 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatments for Alpha-1 Breakdown Data by Type
4.1 Global Treatments for Alpha-1 Historic Market Size by Type (2024-2024)
4.2 Global Treatments for Alpha-1 Forecasted Market Size by Type (2024-2034)
5 Treatments for Alpha-1 Breakdown Data by Application
5.1 Global Treatments for Alpha-1 Historic Market Size by Application (2024-2024)
5.2 Global Treatments for Alpha-1 Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Treatments for Alpha-1 Market Size (2024-2034)
6.2 North America Treatments for Alpha-1 Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Treatments for Alpha-1 Market Size by Country (2024-2024)
6.4 North America Treatments for Alpha-1 Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Treatments for Alpha-1 Market Size (2024-2034)
7.2 Europe Treatments for Alpha-1 Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Treatments for Alpha-1 Market Size by Country (2024-2024)
7.4 Europe Treatments for Alpha-1 Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Treatments for Alpha-1 Market Size (2024-2034)
8.2 Asia-Pacific Treatments for Alpha-1 Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Treatments for Alpha-1 Market Size by Region (2024-2024)
8.4 Asia-Pacific Treatments for Alpha-1 Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Treatments for Alpha-1 Market Size (2024-2034)
9.2 Latin America Treatments for Alpha-1 Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Treatments for Alpha-1 Market Size by Country (2024-2024)
9.4 Latin America Treatments for Alpha-1 Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatments for Alpha-1 Market Size (2024-2034)
10.2 Middle East & Africa Treatments for Alpha-1 Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Treatments for Alpha-1 Market Size by Country (2024-2024)
10.4 Middle East & Africa Treatments for Alpha-1 Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Treatments for Alpha-1 Introduction
11.1.4 Pfizer Revenue in Treatments for Alpha-1 Business (2024-2024)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Treatments for Alpha-1 Introduction
11.2.4 GlaxoSmithKline Revenue in Treatments for Alpha-1 Business (2024-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Treatments for Alpha-1 Introduction
11.3.4 AstraZeneca Revenue in Treatments for Alpha-1 Business (2024-2024)
11.3.5 AstraZeneca Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Treatments for Alpha-1 Introduction
11.4.4 Boehringer Ingelheim Revenue in Treatments for Alpha-1 Business (2024-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Treatments for Alpha-1 Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Treatments for Alpha-1 Business (2024-2024)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Takeda
11.6.1 Takeda Company Detail
11.6.2 Takeda Business Overview
11.6.3 Takeda Treatments for Alpha-1 Introduction
11.6.4 Takeda Revenue in Treatments for Alpha-1 Business (2024-2024)
11.6.5 Takeda Recent Development
11.7 Baxter
11.7.1 Baxter Company Detail
11.7.2 Baxter Business Overview
11.7.3 Baxter Treatments for Alpha-1 Introduction
11.7.4 Baxter Revenue in Treatments for Alpha-1 Business (2024-2024)
11.7.5 Baxter Recent Development
11.8 Grifols
11.8.1 Grifols Company Detail
11.8.2 Grifols Business Overview
11.8.3 Grifols Treatments for Alpha-1 Introduction
11.8.4 Grifols Revenue in Treatments for Alpha-1 Business (2024-2024)
11.8.5 Grifols Recent Development
11.9 CSL Behring
11.9.1 CSL Behring Company Detail
11.9.2 CSL Behring Business Overview
11.9.3 CSL Behring Treatments for Alpha-1 Introduction
11.9.4 CSL Behring Revenue in Treatments for Alpha-1 Business (2024-2024)
11.9.5 CSL Behring Recent Development
11.10 Kamada Ltd
11.10.1 Kamada Ltd Company Detail
11.10.2 Kamada Ltd Business Overview
11.10.3 Kamada Ltd Treatments for Alpha-1 Introduction
11.10.4 Kamada Ltd Revenue in Treatments for Alpha-1 Business (2024-2024)
11.10.5 Kamada Ltd Recent Development
11.11 Chiesi Pharmaceuticals
11.11.1 Chiesi Pharmaceuticals Company Detail
11.11.2 Chiesi Pharmaceuticals Business Overview
11.11.3 Chiesi Pharmaceuticals Treatments for Alpha-1 Introduction
11.11.4 Chiesi Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2024-2024)
11.11.5 Chiesi Pharmaceuticals Recent Development
11.12 Kedrion Group
11.12.1 Kedrion Group Company Detail
11.12.2 Kedrion Group Business Overview
11.12.3 Kedrion Group Treatments for Alpha-1 Introduction
11.12.4 Kedrion Group Revenue in Treatments for Alpha-1 Business (2024-2024)
11.12.5 Kedrion Group Recent Development
11.13 Vertex Pharmaceuticals
11.13.1 Vertex Pharmaceuticals Company Detail
11.13.2 Vertex Pharmaceuticals Business Overview
11.13.3 Vertex Pharmaceuticals Treatments for Alpha-1 Introduction
11.13.4 Vertex Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2024-2024)
11.13.5 Vertex Pharmaceuticals Recent Development
11.14 ProMetic Life Sciences
11.14.1 ProMetic Life Sciences Company Detail
11.14.2 ProMetic Life Sciences Business Overview
11.14.3 ProMetic Life Sciences Treatments for Alpha-1 Introduction
11.14.4 ProMetic Life Sciences Revenue in Treatments for Alpha-1 Business (2024-2024)
11.14.5 ProMetic Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Treatments for Alpha-1 Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Augmentation Therapy
Table 3. Key Players of Cystic Fibrosis(CF)
Table 4. Key Players of Non-CF Bronchiectasis(NCFB)
Table 5. Key Players of Diabetes
Table 6. Key Players of Other
Table 7. Global Treatments for Alpha-1 Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Treatments for Alpha-1 Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 9. Global Treatments for Alpha-1 Market Size by Region (2024-2024) & (US$ Million)
Table 10. Global Treatments for Alpha-1 Market Share by Region (2024-2024)
Table 11. Global Treatments for Alpha-1 Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Treatments for Alpha-1 Market Share by Region (2024-2034)
Table 13. Treatments for Alpha-1 Market Trends
Table 14. Treatments for Alpha-1 Market Drivers
Table 15. Treatments for Alpha-1 Market Challenges
Table 16. Treatments for Alpha-1 Market Restraints
Table 17. Global Treatments for Alpha-1 Revenue by Players (2024-2024) & (US$ Million)
Table 18. Global Treatments for Alpha-1 Market Share by Players (2024-2024)
Table 19. Global Top Treatments for Alpha-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatments for Alpha-1 as of 2022)
Table 20. Ranking of Global Top Treatments for Alpha-1 Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Treatments for Alpha-1 Revenue (CR5 and HHI) & (2024-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Treatments for Alpha-1 Product Solution and Service
Table 24. Date of Enter into Treatments for Alpha-1 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Treatments for Alpha-1 Market Size by Type (2024-2024) & (US$ Million)
Table 27. Global Treatments for Alpha-1 Revenue Market Share by Type (2024-2024)
Table 28. Global Treatments for Alpha-1 Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Treatments for Alpha-1 Revenue Market Share by Type (2024-2034)
Table 30. Global Treatments for Alpha-1 Market Size by Application (2024-2024) & (US$ Million)
Table 31. Global Treatments for Alpha-1 Revenue Market Share by Application (2024-2024)
Table 32. Global Treatments for Alpha-1 Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Treatments for Alpha-1 Revenue Market Share by Application (2024-2034)
Table 34. North America Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. North America Treatments for Alpha-1 Market Size by Country (2024-2024) & (US$ Million)
Table 36. North America Treatments for Alpha-1 Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 38. Europe Treatments for Alpha-1 Market Size by Country (2024-2024) & (US$ Million)
Table 39. Europe Treatments for Alpha-1 Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Treatments for Alpha-1 Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Asia-Pacific Treatments for Alpha-1 Market Size by Region (2024-2024) & (US$ Million)
Table 42. Asia-Pacific Treatments for Alpha-1 Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Latin America Treatments for Alpha-1 Market Size by Country (2024-2024) & (US$ Million)
Table 45. Latin America Treatments for Alpha-1 Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 47. Middle East & Africa Treatments for Alpha-1 Market Size by Country (2024-2024) & (US$ Million)
Table 48. Middle East & Africa Treatments for Alpha-1 Market Size by Country (2024-2034) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Treatments for Alpha-1 Product
Table 52. Pfizer Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. GlaxoSmithKline Company Detail
Table 55. GlaxoSmithKline Business Overview
Table 56. GlaxoSmithKline Treatments for Alpha-1 Product
Table 57. GlaxoSmithKline Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 58. GlaxoSmithKline Recent Development
Table 59. AstraZeneca Company Detail
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Treatments for Alpha-1 Product
Table 62. AstraZeneca Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 63. AstraZeneca Recent Development
Table 64. Boehringer Ingelheim Company Detail
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim Treatments for Alpha-1 Product
Table 67. Boehringer Ingelheim Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 68. Boehringer Ingelheim Recent Development
Table 69. Teva Pharmaceutical Industries Company Detail
Table 70. Teva Pharmaceutical Industries Business Overview
Table 71. Teva Pharmaceutical Industries Treatments for Alpha-1 Product
Table 72. Teva Pharmaceutical Industries Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 73. Teva Pharmaceutical Industries Recent Development
Table 74. Takeda Company Detail
Table 75. Takeda Business Overview
Table 76. Takeda Treatments for Alpha-1 Product
Table 77. Takeda Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 78. Takeda Recent Development
Table 79. Baxter Company Detail
Table 80. Baxter Business Overview
Table 81. Baxter Treatments for Alpha-1 Product
Table 82. Baxter Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 83. Baxter Recent Development
Table 84. Grifols Company Detail
Table 85. Grifols Business Overview
Table 86. Grifols Treatments for Alpha-1 Product
Table 87. Grifols Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 88. Grifols Recent Development
Table 89. CSL Behring Company Detail
Table 90. CSL Behring Business Overview
Table 91. CSL Behring Treatments for Alpha-1 Product
Table 92. CSL Behring Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 93. CSL Behring Recent Development
Table 94. Kamada Ltd Company Detail
Table 95. Kamada Ltd Business Overview
Table 96. Kamada Ltd Treatments for Alpha-1 Product
Table 97. Kamada Ltd Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 98. Kamada Ltd Recent Development
Table 99. Chiesi Pharmaceuticals Company Detail
Table 100. Chiesi Pharmaceuticals Business Overview
Table 101. Chiesi Pharmaceuticals Treatments for Alpha-1 Product
Table 102. Chiesi Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 103. Chiesi Pharmaceuticals Recent Development
Table 104. Kedrion Group Company Detail
Table 105. Kedrion Group Business Overview
Table 106. Kedrion Group Treatments for Alpha-1 Product
Table 107. Kedrion Group Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 108. Kedrion Group Recent Development
Table 109. Vertex Pharmaceuticals Company Detail
Table 110. Vertex Pharmaceuticals Business Overview
Table 111. Vertex Pharmaceuticals Treatments for Alpha-1 Product
Table 112. Vertex Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 113. Vertex Pharmaceuticals Recent Development
Table 114. ProMetic Life Sciences Company Detail
Table 115. ProMetic Life Sciences Business Overview
Table 116. ProMetic Life Sciences Treatments for Alpha-1 Product
Table 117. ProMetic Life Sciences Revenue in Treatments for Alpha-1 Business (2024-2024) & (US$ Million)
Table 118. ProMetic Life Sciences Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatments for Alpha-1 Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Treatments for Alpha-1 Market Share by Type: 2022 VS 2034
Figure 3. Augmentation Therapy Features
Figure 4. Cystic Fibrosis(CF) Features
Figure 5. Non-CF Bronchiectasis(NCFB) Features
Figure 6. Diabetes Features
Figure 7. Other Features
Figure 8. Global Treatments for Alpha-1 Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Treatments for Alpha-1 Market Share by Application: 2022 VS 2034
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Pharmacies Case Studies
Figure 13. Treatments for Alpha-1 Report Years Considered
Figure 14. Global Treatments for Alpha-1 Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 15. Global Treatments for Alpha-1 Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Treatments for Alpha-1 Market Share by Region: 2022 VS 2034
Figure 17. Global Treatments for Alpha-1 Market Share by Players in 2022
Figure 18. Global Top Treatments for Alpha-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatments for Alpha-1 as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Treatments for Alpha-1 Revenue in 2022
Figure 20. North America Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. North America Treatments for Alpha-1 Market Share by Country (2024-2034)
Figure 22. United States Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Canada Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Europe Treatments for Alpha-1 Market Share by Country (2024-2034)
Figure 26. Germany Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. France Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. U.K. Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Italy Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Russia Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Nordic Countries Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Asia-Pacific Treatments for Alpha-1 Market Share by Region (2024-2034)
Figure 34. China Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Japan Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. South Korea Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Southeast Asia Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. India Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Australia Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Latin America Treatments for Alpha-1 Market Share by Country (2024-2034)
Figure 42. Mexico Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Brazil Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Treatments for Alpha-1 Market Share by Country (2024-2034)
Figure 46. Turkey Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Saudi Arabia Treatments for Alpha-1 Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 53. Takeda Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 54. Baxter Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 55. Grifols Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 56. CSL Behring Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 57. Kamada Ltd Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 58. Chiesi Pharmaceuticals Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 59. Kedrion Group Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 60. Vertex Pharmaceuticals Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 61. ProMetic Life Sciences Revenue Growth Rate in Treatments for Alpha-1 Business (2024-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed